These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8149659)

  • 21. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ; Man XY; Li W; Zhou J; Landeck L; Cai SQ; Zheng M
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intralesional and anatomopathologic features of psoriatic erythroderma].
    Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
    Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
    Terlizzese M; Simoni P; Antonetti F
    J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin.
    Takematsu H; Ohmoto Y; Tagami H
    Tohoku J Exp Med; 1990 Jul; 161(3):159-69. PubMed ID: 2247888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S; Sauder DN
    Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
    Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigó M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
    Ann N Y Acad Sci; 2007 Sep; 1110():578-89. PubMed ID: 17911474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
    Wallace HJ; Stacey MC
    J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
    Pan W; Csernus B; Kastin AJ
    J Mol Neurosci; 2003; 21(2):173-84. PubMed ID: 14593216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
    Takematsu H; Tagami H
    Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
    Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin.
    Brunner PM; Glitzner E; Reininger B; Klein I; Stary G; Mildner M; Uhrin P; Sibilia M; Stingl G
    Exp Dermatol; 2015 Jul; 24(7):522-8. PubMed ID: 25828150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
    Amrani Y; Panettieri RA; Frossard N; Bronner C
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
    van Deuren M; Frieling JT; van der Ven-Jongekrijg J; Neeleman C; Russel FG; van Lier HJ; Bartelink AK; van der Meer JW
    Clin Infect Dis; 1998 Apr; 26(4):918-23. PubMed ID: 9564476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.
    Slowik MR; De Luca LG; Fiers W; Pober JS
    Am J Pathol; 1993 Dec; 143(6):1724-30. PubMed ID: 7504889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM; Feldmann M; Di Padova F; Brennan FM
    Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
    Sheehan KC; Pinckard JK; Arthur CD; Dehner LP; Goeddel DV; Schreiber RD
    J Exp Med; 1995 Feb; 181(2):607-17. PubMed ID: 7836916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.